H.R. 8652 · 116th Congress
Dialysis-Related Amyloidosis Treatment Act of 2020
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
BabinSponsorNo cosponsors.
This bill provides for Medicare coverage and payment of treatments for dialysis-related amyloidosis (a complication of kidney failure that can occur as a result of long-term dialysis).
What it does: CRS summary · Introduced in House · Oct 23, 2020
Dialysis-Related Amyloidosis Treatment Act of 2020
This bill provides for Medicare coverage and payment of treatments for dialysis-related amyloidosis (a complication of kidney failure that can occur as a result of long-term dialysis).
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Dialysis-Related Amyloidosis Treatment Act of 2020
Latest action (Oct 23, 2020): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Policy area: Health · Origin: House · Introduced: Oct 23, 2020
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.